Trade Summary

4 days ago, Fitzpatrick Alexander A, serving as Chief Legal Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 3,355 shares at $10.00 per share, for a total transaction value of $33,550.00. Following this transaction, Fitzpatrick Alexander A now holds 90,910 shares of SPRY.

This sale represents a 3.56% decrease in Fitzpatrick Alexander A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, June 12, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, June 13, 2026 (accepted Jun 12, 8:04 PM ET), 1 day after the trade was made.

ARS Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.